How the minefield that is socia media could actually prove beneficial for the world of pharma.
Top Stories
Alternative markets for pharmaceutical companies
Why emerging markets are the pharmaceutical industry’s next big thing.
Pharma manufacturing supply chain
Amgen’s Madhavan Balachandran on why persistence is key to implementing an Operational Excellence campaign
Miracle cure?
In an ailing industry desperately casting about for a way to save itself, the rapidly emerging field of pharmacogenomics could provide a life-saving tonic. By Marie Shields
The innovation agenda
Joe Miletich tells NGP why in these uncertain times, it's more important than ever for pharmaceutical R&D to pursue novel compounds.
Back on track
Martin Mackay fills NGP in on his plan to improve the ROI of Pfizer's R&D.